Russia suspends Monsanto corn imports

Sep 26, 2012

Russia has temporarily suspended importing genetically-modified corn made by the US biotech giant Monsanto after a controversial study linked it to cancer in rats.

The Rospotrebnadzor consumer protection agency said it was studying the French and had commissioned help from a Russian institute to interpret the data further.

"Until we receive the full information in this case, the import and sale of genetically modified NK603 corn is being temporarily suspended," the agency said in a statement released on its website this week.

The study has been heavily criticised in part because the French researchers leading it have refused to let the European Union's food verify its results.

The University of Caen scientists argue that the agency is biased because it approved the corn in the first place.

But other US and European institutes have also questioned the size of the sample pool and completeness of the researchers' data.

NK603 is a type of corn that has been engineered to make it resistant to Roundup herbicide and is used by farmers to maximise yields.

A spokesman for Monsanto played down the importance of Russia's import disruption to his company.

"Russia is a net exporter of grain, so the actual impact of their temporary suspension, if any, is likely to be small," the spokesman was quoted as saying in the online edition of the .

Explore further: The origin of the language of life

add to favorites email to friend print save as pdf

Related Stories

Recommended for you

The origin of the language of life

Dec 19, 2014

The genetic code is the universal language of life. It describes how information is encoded in the genetic material and is the same for all organisms from simple bacteria to animals to humans. However, the ...

Quest to unravel mysteries of our gene network

Dec 18, 2014

There are roughly 27,000 genes in the human body, all but a relative few of them connected through an intricate and complex network that plays a dominant role in shaping our physiological structure and functions.

EU court clears stem cell patenting

Dec 18, 2014

A human egg used to produce stem cells but unable to develop into a viable embryo can be patented, the European Court of Justice ruled on Thursday.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.